182 related articles for article (PubMed ID: 25449777)
1. Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer.
Togashi Y; Kogita A; Sakamoto H; Hayashi H; Terashima M; de Velasco MA; Sakai K; Fujita Y; Tomida S; Kitano M; Okuno K; Kudo M; Nishio K
Cancer Lett; 2015 Jan; 356(2 Pt B):819-27. PubMed ID: 25449777
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of activin A in oral squamous cell carcinoma: association with poor prognosis and tumor progression.
Chang KP; Kao HK; Liang Y; Cheng MH; Chang YL; Liu SC; Lin YC; Ko TY; Lee YS; Tsai CL; Wang TH; Hao SP; Tsai CN
Ann Surg Oncol; 2010 Jul; 17(7):1945-56. PubMed ID: 20309641
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma.
Yan TT; Fu XL; Li J; Bian YN; Liu DJ; Hua R; Ren LL; Li CT; Sun YW; Chen HY; Fang JY; Hong J
Oncotarget; 2015 Nov; 6(35):37028-42. PubMed ID: 26498693
[TBL] [Abstract][Full Text] [Related]
4. The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy.
Zhong X; Pons M; Poirier C; Jiang Y; Liu J; Sandusky GE; Shahda S; Nakeeb A; Schmidt CM; House MG; Ceppa EP; Zyromski NJ; Liu Y; Jiang G; Couch ME; Koniaris LG; Zimmers TA
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1083-1101. PubMed ID: 31286691
[TBL] [Abstract][Full Text] [Related]
5. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.
Jiang J; Li Z; Yu C; Chen M; Tian S; Sun C
Cancer Lett; 2015 Jan; 356(2 Pt B):962-70. PubMed ID: 25444909
[TBL] [Abstract][Full Text] [Related]
6. Leptin signaling enhances cell invasion and promotes the metastasis of human pancreatic cancer via increasing MMP-13 production.
Fan Y; Gan Y; Shen Y; Cai X; Song Y; Zhao F; Yao M; Gu J; Tu H
Oncotarget; 2015 Jun; 6(18):16120-34. PubMed ID: 25948792
[TBL] [Abstract][Full Text] [Related]
7. Activin A stimulates AKR1C3 expression and growth in human prostate cancer.
Hofland J; van Weerden WM; Steenbergen J; Dits NF; Jenster G; de Jong FH
Endocrinology; 2012 Dec; 153(12):5726-34. PubMed ID: 23024260
[TBL] [Abstract][Full Text] [Related]
8. Collapsin response mediator protein 4 expression is associated with liver metastasis and poor survival in pancreatic cancer.
Hiroshima Y; Nakamura F; Miyamoto H; Mori R; Taniguchi K; Matsuyama R; Akiyama H; Tanaka K; Ichikawa Y; Kato S; Kobayashi N; Kubota K; Nagashima Y; Goshima Y; Endo I
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S369-78. PubMed ID: 22805864
[TBL] [Abstract][Full Text] [Related]
9. Activin-β(c) reduces reproductive tumour progression and abolishes cancer-associated cachexia in inhibin-deficient mice.
Gold E; Marino FE; Harrison C; Makanji Y; Risbridger G
J Pathol; 2013 Mar; 229(4):599-607. PubMed ID: 23180294
[TBL] [Abstract][Full Text] [Related]
10. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
Bi YL; Min M; Shen W; Liu Y
Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
[TBL] [Abstract][Full Text] [Related]
11. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.
Fujisawa T; Joshi B; Nakajima A; Puri RK
Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609
[TBL] [Abstract][Full Text] [Related]
12. CUX1: a modulator of tumour aggressiveness in pancreatic neuroendocrine neoplasms.
Krug S; Kühnemuth B; Griesmann H; Neesse A; Mühlberg L; Boch M; Kortenhaus J; Fendrich V; Wiese D; Sipos B; Friemel J; Gress TM; Michl P
Endocr Relat Cancer; 2014; 21(6):879-90. PubMed ID: 25248790
[TBL] [Abstract][Full Text] [Related]
13. Activin a causes cancer cell aggressiveness in esophageal squamous cell carcinoma cells.
Yoshinaga K; Yamashita K; Mimori K; Tanaka F; Inoue H; Mori M
Ann Surg Oncol; 2008 Jan; 15(1):96-103. PubMed ID: 17909904
[TBL] [Abstract][Full Text] [Related]
14. Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells.
Steller MD; Shaw TJ; Vanderhyden BC; Ethier JF
Mol Cancer Res; 2005 Jan; 3(1):50-61. PubMed ID: 15671249
[TBL] [Abstract][Full Text] [Related]
15. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of activins promotes muscle wasting and cachexia.
Chen JL; Walton KL; Winbanks CE; Murphy KT; Thomson RE; Makanji Y; Qian H; Lynch GS; Harrison CA; Gregorevic P
FASEB J; 2014 Apr; 28(4):1711-23. PubMed ID: 24378873
[TBL] [Abstract][Full Text] [Related]
17. Sonic hedgehog paracrine signaling activates stromal cells to promote perineural invasion in pancreatic cancer.
Li X; Wang Z; Ma Q; Xu Q; Liu H; Duan W; Lei J; Ma J; Wang X; Lv S; Han L; Li W; Guo J; Guo K; Zhang D; Wu E; Xie K
Clin Cancer Res; 2014 Aug; 20(16):4326-38. PubMed ID: 24947933
[TBL] [Abstract][Full Text] [Related]
18. Activin A suppresses neuroblastoma xenograft tumor growth via antimitotic and antiangiogenic mechanisms.
Panopoulou E; Murphy C; Rasmussen H; Bagli E; Rofstad EK; Fotsis T
Cancer Res; 2005 Mar; 65(5):1877-86. PubMed ID: 15753386
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic tumor mass in a xenograft mouse model is decreased by treatment with therapeutic stem cells following introduction of therapeutic genes.
Kim DJ; Yi BR; Lee HR; Kim SU; Choi KC
Oncol Rep; 2013 Sep; 30(3):1129-36. PubMed ID: 23807450
[TBL] [Abstract][Full Text] [Related]
20. Activin A balances Sertoli and germ cell proliferation in the fetal mouse testis.
Mendis SH; Meachem SJ; Sarraj MA; Loveland KL
Biol Reprod; 2011 Feb; 84(2):379-91. PubMed ID: 20926807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
